- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
According to this study, over the next five years the Anthrax Vaccines market will register a 7.9%% CAGR in terms of revenue, the global market size will reach $ 777.6 million by 2025, from $ 574 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anthrax Vaccines business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Anthrax Vaccines market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Anthrax Vaccines, covering the supply chain analysis, impact assessment to the Anthrax Vaccines market size growth rate in several scenarios, and the measures to be undertaken by Anthrax Vaccines companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Live Vaccines
Cell free PA Vaccines
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Human Use
Animal Use
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Emergent BioSolutions
CAVAC
Merial
Zoetis
Bayer Sanidad Animal
Merck
Tiankang
Colorado Serum
Biogénesis-Bago
PharmAthene
Prondil
Indian Immunologicals
CDV
Rosenbusch
CVCRI
Vecol
Ceva Santé Animale
IVPM
Agrovet
Botswana Vaccine Institute
JOVAC
Intervac
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Anthrax Vaccines consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Anthrax Vaccines market by identifying its various subsegments.
Focuses on the key global Anthrax Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anthrax Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Anthrax Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anthrax Vaccines Consumption 2015-2025
2.1.2 Anthrax Vaccines Consumption CAGR by Region
2.2 Anthrax Vaccines Segment by Type
2.2.1 Live Vaccines
2.2.2 Cell free PA Vaccines
2.3 Anthrax Vaccines Consumption by Type
2.3.1 Global Anthrax Vaccines Consumption Market Share by Type (2015-2020)
2.3.2 Global Anthrax Vaccines Revenue and Market Share by Type (2015-2020)
2.3.3 Global Anthrax Vaccines Sale Price by Type (2015-2020)
2.4 Anthrax Vaccines Segment by Application
2.4.1 Human Use
2.4.2 Animal Use
2.5 Anthrax Vaccines Consumption by Application
2.5.1 Global Anthrax Vaccines Consumption Market Share by Type (2015-2020)
2.5.2 Global Anthrax Vaccines Value and Market Share by Type (2015-2020)
2.5.3 Global Anthrax Vaccines Sale Price by Type (2015-2020)
3 Global Anthrax Vaccines by Company
3.1 Global Anthrax Vaccines Sales Market Share by Company
3.1.1 Global Anthrax Vaccines Sales by Company (2018-2020)
3.1.2 Global Anthrax Vaccines Sales Market Share by Company (2018-2020)
3.2 Global Anthrax Vaccines Revenue Market Share by Company
3.2.1 Global Anthrax Vaccines Revenue by Company (2018-2020)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Company (2018-2020)
3.3 Global Anthrax Vaccines Sale Price by Company
3.4 Global Anthrax Vaccines Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Anthrax Vaccines Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Anthrax Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Anthrax Vaccines by Regions
4.1 Anthrax Vaccines by Regions
4.2 Americas Anthrax Vaccines Consumption Growth
4.3 APAC Anthrax Vaccines Consumption Growth
4.4 Europe Anthrax Vaccines Consumption Growth
4.5 Middle East & Africa Anthrax Vaccines Consumption Growth
5 Americas
5.1 Americas Anthrax Vaccines Consumption by Countries
5.1.1 Americas Anthrax Vaccines Consumption by Countries (2015-2020)
5.1.2 Americas Anthrax Vaccines Value by Countries (2015-2020)
5.2 Americas Anthrax Vaccines Consumption by Type
5.3 Americas Anthrax Vaccines Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Anthrax Vaccines Consumption by Regions
6.1.1 APAC Anthrax Vaccines Consumption by Regions (2015-2020)
6.1.2 APAC Anthrax Vaccines Value by Regions (2015-2020)
6.2 APAC Anthrax Vaccines Consumption by Type
6.3 APAC Anthrax Vaccines Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Anthrax Vaccines by Countries
7.1.1 Europe Anthrax Vaccines Consumption by Countries (2015-2020)
7.1.2 Europe Anthrax Vaccines Value by Countries (2015-2020)
7.2 Europe Anthrax Vaccines Consumption by Type
7.3 Europe Anthrax Vaccines Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Anthrax Vaccines by Countries
8.1.1 Middle East & Africa Anthrax Vaccines Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Anthrax Vaccines Value by Countries (2015-2020)
8.2 Middle East & Africa Anthrax Vaccines Consumption by Type
8.3 Middle East & Africa Anthrax Vaccines Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Anthrax Vaccines Distributors
10.3 Anthrax Vaccines Customer
11 Global Anthrax Vaccines Market Forecast
11.1 Global Anthrax Vaccines Consumption Forecast (2021-2025)
11.2 Global Anthrax Vaccines Forecast by Regions
11.2.1 Global Anthrax Vaccines Forecast by Regions (2021-2025)
11.2.2 Global Anthrax Vaccines Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Anthrax Vaccines Forecast by Type
11.8 Global Anthrax Vaccines Forecast by Application
12 Key Players Analysis
12.1 Emergent BioSolutions
12.1.1 Company Information
12.1.2 Anthrax Vaccines Product Offered
12.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Emergent BioSolutions Latest Developments
12.2 CAVAC
12.2.1 Company Information
12.2.2 Anthrax Vaccines Product Offered
12.2.3 CAVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 CAVAC Latest Developments
12.3 Merial
12.3.1 Company Information
12.3.2 Anthrax Vaccines Product Offered
12.3.3 Merial Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Merial Latest Developments
12.4 Zoetis
12.4.1 Company Information
12.4.2 Anthrax Vaccines Product Offered
12.4.3 Zoetis Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Zoetis Latest Developments
12.5 Bayer Sanidad Animal
12.5.1 Company Information
12.5.2 Anthrax Vaccines Product Offered
12.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Bayer Sanidad Animal Latest Developments
12.6 Merck
12.6.1 Company Information
12.6.2 Anthrax Vaccines Product Offered
12.6.3 Merck Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Merck Latest Developments
12.7 Tiankang
12.7.1 Company Information
12.7.2 Anthrax Vaccines Product Offered
12.7.3 Tiankang Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Tiankang Latest Developments
12.8 Colorado Serum
12.8.1 Company Information
12.8.2 Anthrax Vaccines Product Offered
12.8.3 Colorado Serum Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Colorado Serum Latest Developments
12.9 Biogénesis-Bago
12.9.1 Company Information
12.9.2 Anthrax Vaccines Product Offered
12.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Biogénesis-Bago Latest Developments
12.10 PharmAthene
12.10.1 Company Information
12.10.2 Anthrax Vaccines Product Offered
12.10.3 PharmAthene Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 PharmAthene Latest Developments
12.11 Prondil
12.11.1 Company Information
12.11.2 Anthrax Vaccines Product Offered
12.11.3 Prondil Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Prondil Latest Developments
12.12 Indian Immunologicals
12.12.1 Company Information
12.12.2 Anthrax Vaccines Product Offered
12.12.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Indian Immunologicals Latest Developments
12.13 CDV
12.13.1 Company Information
12.13.2 Anthrax Vaccines Product Offered
12.13.3 CDV Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 CDV Latest Developments
12.14 Rosenbusch
12.14.1 Company Information
12.14.2 Anthrax Vaccines Product Offered
12.14.3 Rosenbusch Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 Rosenbusch Latest Developments
12.15 CVCRI
12.15.1 Company Information
12.15.2 Anthrax Vaccines Product Offered
12.15.3 CVCRI Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.15.4 Main Business Overview
12.15.5 CVCRI Latest Developments
12.16 Vecol
12.16.1 Company Information
12.16.2 Anthrax Vaccines Product Offered
12.16.3 Vecol Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.16.4 Main Business Overview
12.16.5 Vecol Latest Developments
12.17 Ceva Santé Animale
12.17.1 Company Information
12.17.2 Anthrax Vaccines Product Offered
12.17.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.17.4 Main Business Overview
12.17.5 Ceva Santé Animale Latest Developments
12.18 IVPM
12.18.1 Company Information
12.18.2 Anthrax Vaccines Product Offered
12.18.3 IVPM Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.18.4 Main Business Overview
12.18.5 IVPM Latest Developments
12.19 Agrovet
12.19.1 Company Information
12.19.2 Anthrax Vaccines Product Offered
12.19.3 Agrovet Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.19.4 Main Business Overview
12.19.5 Agrovet Latest Developments
12.20 Botswana Vaccine Institute
12.20.1 Company Information
12.20.2 Anthrax Vaccines Product Offered
12.20.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.20.4 Main Business Overview
12.20.5 Botswana Vaccine Institute Latest Developments
12.21 JOVAC
12.21.1 Company Information
12.21.2 Anthrax Vaccines Product Offered
12.21.3 JOVAC Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.21.4 Main Business Overview
12.21.5 JOVAC Latest Developments
12.22 Intervac
12.22.1 Company Information
12.22.2 Anthrax Vaccines Product Offered
12.22.3 Intervac Anthrax Vaccines Sales, Revenue, Price and Gross Margin (2018-2020)
12.22.4 Main Business Overview
12.22.5 Intervac Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Anthrax Vaccines Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Live Vaccines
Table 5. Major Players of Cell free PA Vaccines
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Anthrax Vaccines Consumption Market Share by Type (2015-2020)
Table 8. Global Anthrax Vaccines Revenue by Type (2015-2020) ($ million)
Table 9. Global Anthrax Vaccines Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Anthrax Vaccines Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Anthrax Vaccines Consumption Market Share by Application (2015-2020)
Table 13. Global Anthrax Vaccines Value by Application (2015-2020)
Table 14. Global Anthrax Vaccines Value Market Share by Application (2015-2020)
Table 15. Global Anthrax Vaccines Sale Price by Application (2015-2020)
Table 16. Global Anthrax Vaccines Sales by Company (2017-2019) (M Doses)
Table 17. Global Anthrax Vaccines Sales Market Share by Company (2017-2019)
Table 18. Global Anthrax Vaccines Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Anthrax Vaccines Revenue Market Share by Company (2017-2019)
Table 20. Global Anthrax Vaccines Sale Price by Company (2017-2019)
Table 21. Global Anthrax Vaccines Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Anthrax Vaccines Products Offered
Table 23. Anthrax Vaccines Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Anthrax Vaccines Consumption by Regions 2015-2020 (M Doses)
Table 25. Global Anthrax Vaccines Consumption Market Share by Regions 2015-2020
Table 26. Global Anthrax Vaccines Value by Regions 2015-2020 ($ Millions)
Table 27. Global Anthrax Vaccines Value Market Share by Regions 2015-2020
Table 28. Americas Anthrax Vaccines Consumption by Countries (2015-2020) (M Doses)
Table 29. Americas Anthrax Vaccines Consumption Market Share by Countries (2015-2020)
Table 30. Americas Anthrax Vaccines Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Anthrax Vaccines Value Market Share by Countries (2015-2020)
Table 32. Americas Anthrax Vaccines Consumption by Type (2015-2020) (M Doses)
Table 33. Americas Anthrax Vaccines Consumption Market Share by Type (2015-2020)
Table 34. Americas Anthrax Vaccines Consumption by Application (2015-2020) (M Doses)
Table 35. Americas Anthrax Vaccines Consumption Market Share by Application (2015-2020)
Table 36. APAC Anthrax Vaccines Consumption by Countries (2015-2020) (M Doses)
Table 37. APAC Anthrax Vaccines Consumption Market Share by Countries (2015-2020)
Table 38. APAC Anthrax Vaccines Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Anthrax Vaccines Value Market Share by Regions (2015-2020)
Table 40. APAC Anthrax Vaccines Consumption by Type (2015-2020) (M Doses)
Table 41. APAC Anthrax Vaccines Consumption Market Share by Type (2015-2020)
Table 42. APAC Anthrax Vaccines Consumption by Application (2015-2020) (M Doses)
Table 43. APAC Anthrax Vaccines Consumption Market Share by Application (2015-2020)
Table 44. Europe Anthrax Vaccines Consumption by Countries (2015-2020) (M Doses)
Table 45. Europe Anthrax Vaccines Consumption Market Share by Countries (2015-2020)
Table 46. Europe Anthrax Vaccines Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Anthrax Vaccines Value Market Share by Countries (2015-2020)
Table 48. Europe Anthrax Vaccines Consumption by Type (2015-2020) (M Doses)
Table 49. Europe Anthrax Vaccines Consumption Market Share by Type (2015-2020)
Table 50. Europe Anthrax Vaccines Consumption by Application (2015-2020) (M Doses)
Table 51. Europe Anthrax Vaccines Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Anthrax Vaccines Consumption by Countries (2015-2020) (M Doses)
Table 53. Middle East & Africa Anthrax Vaccines Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Anthrax Vaccines Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Anthrax Vaccines Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Anthrax Vaccines Consumption by Type (2015-2020) (M Doses)
Table 57. Middle East & Africa Anthrax Vaccines Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Anthrax Vaccines Consumption by Application (2015-2020) (M Doses)
Table 59. Middle East & Africa Anthrax Vaccines Consumption Market Share by Application (2015-2020)
Table 60. Anthrax Vaccines Distributors List
Table 61. Anthrax Vaccines Customer List
Table 62. Global Anthrax Vaccines Consumption Forecast by Countries (2021-2025) (M Doses)
Table 63. Global Anthrax Vaccines Consumption Market Forecast by Regions
Table 64. Global Anthrax Vaccines Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Anthrax Vaccines Value Market Share Forecast by Regions
Table 66. Global Anthrax Vaccines Consumption Forecast by Type (2021-2025) (M Doses)
Table 67. Global Anthrax Vaccines Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Anthrax Vaccines Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Anthrax Vaccines Value Market Share Forecast by Type (2021-2025)
Table 70. Global Anthrax Vaccines Consumption Forecast by Application (2021-2025) (M Doses)
Table 71. Global Anthrax Vaccines Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Anthrax Vaccines Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Anthrax Vaccines Value Market Share Forecast by Application (2021-2025)
Table 74. Emergent BioSolutions Product Offered
Table 75. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 76. Emergent BioSolutions Main Business
Table 77. Emergent BioSolutions Latest Developments
Table 78. Emergent BioSolutions Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. CAVAC Product Offered
Table 80. CAVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 81. CAVAC Main Business
Table 82. CAVAC Latest Developments
Table 83. CAVAC Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Merial Product Offered
Table 85. Merial Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 86. Merial Main Business
Table 87. Merial Latest Developments
Table 88. Merial Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Zoetis Product Offered
Table 90. Zoetis Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 91. Zoetis Main Business
Table 92. Zoetis Latest Developments
Table 93. Zoetis Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer Sanidad Animal Product Offered
Table 95. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 96. Bayer Sanidad Animal Main Business
Table 97. Bayer Sanidad Animal Latest Developments
Table 98. Bayer Sanidad Animal Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck Product Offered
Table 100. Merck Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 101. Merck Main Business
Table 102. Merck Latest Developments
Table 103. Merck Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Tiankang Product Offered
Table 105. Tiankang Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. Tiankang Main Business
Table 107. Tiankang Latest Developments
Table 108. Tiankang Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 109. Colorado Serum Product Offered
Table 110. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 111. Colorado Serum Main Business
Table 112. Colorado Serum Latest Developments
Table 113. Colorado Serum Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. Biogénesis-Bago Product Offered
Table 115. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 116. Biogénesis-Bago Main Business
Table 117. Biogénesis-Bago Latest Developments
Table 118. Biogénesis-Bago Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. PharmAthene Product Offered
Table 120. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 121. PharmAthene Main Business
Table 122. PharmAthene Latest Developments
Table 123. PharmAthene Basic Information, Company Total Revenue (in $ million), Anthrax Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. Prondil Product Offered
Table 125. Prondil Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 126. Prondil Main Business
Table 127. Prondil Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 128. Prondil Latest Developments
Table 129. Indian Immunologicals Product Offered
Table 130. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 131. Indian Immunologicals Main Business
Table 132. Indian Immunologicals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 133. Indian Immunologicals Latest Developments
Table 134. CDV Product Offered
Table 135. CDV Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 136. CDV Main Business
Table 137. CDV Latest Developments
Table 138. CDV Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 139. Rosenbusch Product Offered
Table 140. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 141. Rosenbusch Main Business
Table 142. Rosenbusch Latest Developments
Table 143. Rosenbusch Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 144. CVCRI Product Offered
Table 145. CVCRI Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 146. CVCRI Main Business
Table 147. CVCRI Latest Developments
Table 148. CVCRI Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 149. Vecol Product Offered
Table 150. Vecol Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 151. Vecol Main Business
Table 152. Vecol Latest Developments
Table 153. Vecol Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 154. Ceva Santé Animale Product Offered
Table 155. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 156. Ceva Santé Animale Main Business
Table 157. Ceva Santé Animale Latest Developments
Table 158. Ceva Santé Animale Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 159. IVPM Product Offered
Table 160. IVPM Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 161. IVPM Main Business
Table 162. IVPM Latest Developments
Table 163. IVPM Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 164. Agrovet Product Offered
Table 165. Agrovet Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 166. Agrovet Main Business
Table 167. Agrovet Latest Developments
Table 168. Agrovet Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 169. Botswana Vaccine Institute Product Offered
Table 170. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 171. Botswana Vaccine Institute Main Business
Table 172. Botswana Vaccine Institute Latest Developments
Table 173. Botswana Vaccine Institute Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 174. JOVAC Product Offered
Table 175. JOVAC Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 176. JOVAC Main Business
Table 177. JOVAC Latest Developments
Table 178. JOVAC Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 179. Intervac Product Offered
Table 180. Intervac Anthrax Vaccines Sales (M Doses), Revenue ($ Million), Price (USD/K Doses) and Gross Margin (2018-2020E)
Table 181. Intervac Main Business
Table 182. Intervac Latest Developments
Table 183. Intervac Basic Information, Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Anthrax Vaccines
Figure 2. Anthrax Vaccines Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Anthrax Vaccines Consumption Growth Rate 2015-2025 (M Doses)
Figure 5. Global Anthrax Vaccines Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Live Vaccines
Figure 7. Product Picture of Cell free PA Vaccines
Figure 8. Global Anthrax Vaccines Consumption Market Share by Type (2015-2020)
Figure 9. Global Anthrax Vaccines Value Market Share by Type (2015-2020)
Figure 10. Anthrax Vaccines Consumed in Human Use
Figure 11. Global Anthrax Vaccines Market: Human Use (2015-2020) (M Doses)
Figure 12. Global Anthrax Vaccines Market: Human Use (2015-2020) ($ Millions)
Figure 13. Anthrax Vaccines Consumed in Animal Use
Figure 14. Global Anthrax Vaccines Market: Animal Use (2015-2020) (M Doses)
Figure 15. Global Anthrax Vaccines Market: Animal Use (2015-2020) ($ Millions)
Figure 16. Global Anthrax Vaccines Consumption Market Share by Application (2015-2020)
Figure 17. Global Anthrax Vaccines Value Market Share by Application (2015-2020)
Figure 18. Global Anthrax Vaccines Sales Market Share by Company in 2017
Figure 19. Global Anthrax Vaccines Sales Market Share by Company in 2019
Figure 20. Global Anthrax Vaccines Revenue Market Share by Company in 2017
Figure 21. Global Anthrax Vaccines Revenue Market Share by Company in 2019
Figure 22. Global Anthrax Vaccines Sale Price by Company in 2019
Figure 23. Global Anthrax Vaccines Consumption Market Share by Regions 2015-2020
Figure 24. Global Anthrax Vaccines Value Market Share by Regions 2015-2020
Figure 25. Americas Anthrax Vaccines Consumption 2015-2020 (M Doses)
Figure 26. Americas Anthrax Vaccines Value 2015-2020 ($ Millions)
Figure 27. APAC Anthrax Vaccines Consumption 2015-2020 (M Doses)
Figure 28. APAC Anthrax Vaccines Value 2015-2020 ($ Millions)
Figure 29. Europe Anthrax Vaccines Consumption 2015-2020 (M Doses)
Figure 30. Europe Anthrax Vaccines Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Anthrax Vaccines Consumption 2015-2020 (M Doses)
Figure 32. Middle East & Africa Anthrax Vaccines Value 2015-2020 ($ Millions)
Figure 33. Americas Anthrax Vaccines Consumption Market Share by Countries in 2019
Figure 34. Americas Anthrax Vaccines Value Market Share by Countries in 2019
Figure 35. Americas Anthrax Vaccines Consumption Market Share by Type in 2019
Figure 36. Americas Anthrax Vaccines Consumption Market Share by Application in 2019
Figure 37. United States Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 38. United States Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 40. Canada Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 42. Mexico Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Anthrax Vaccines Consumption Market Share by Countries in 2019
Figure 44. APAC Anthrax Vaccines Value Market Share by Regions in 2019
Figure 45. APAC Anthrax Vaccines Consumption Market Share by Type in 2019
Figure 46. APAC Anthrax Vaccines Consumption Market Share by Application in 2019
Figure 47. China Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 48. China Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 50. Japan Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 52. Korea Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 54. Southeast Asia Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 55. India Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 56. India Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 58. Australia Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Anthrax Vaccines Consumption Market Share by Countries in 2019
Figure 60. Europe Anthrax Vaccines Value Market Share by Countries in 2019
Figure 61. Europe Anthrax Vaccines Consumption Market Share by Type in 2019
Figure 62. Europe Anthrax Vaccines Consumption Market Share by Application in 2019
Figure 63. Germany Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 64. Germany Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 65. France Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 66. France Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 67. UK Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 68. UK Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 70. Italy Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 72. Russia Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Anthrax Vaccines Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Anthrax Vaccines Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Anthrax Vaccines Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Anthrax Vaccines Consumption Market Share by Application in 2019
Figure 77. Egypt Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 78. Egypt Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 80. South Africa Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 82. Israel Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 84. Turkey Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Anthrax Vaccines Consumption Growth 2015-2020 (M Doses)
Figure 86. GCC Countries Anthrax Vaccines Value Growth 2015-2020 ($ Millions)
Figure 87. Global Anthrax Vaccines Consumption Growth Rate Forecast (2021-2025) (M Doses)
Figure 88. Global Anthrax Vaccines Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 90. Americas Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 91. APAC Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 92. APAC Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 93. Europe Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 94. Europe Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 96. Middle East & Africa Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 97. United States Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 98. United States Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 99. Canada Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 100. Canada Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 101. Mexico Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 102. Mexico Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 103. Brazil Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 104. Brazil Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 105. China Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 106. China Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 107. Japan Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 108. Japan Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 109. Korea Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 110. Korea Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 112. Southeast Asia Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 113. India Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 114. India Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 115. Australia Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 116. Australia Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 117. Germany Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 118. Germany Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 119. France Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 120. France Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 121. UK Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 122. UK Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 123. Italy Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 124. Italy Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 125. Russia Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 126. Russia Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 127. Spain Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 128. Spain Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 129. Egypt Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 130. Egypt Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 131. South Africa Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 132. South Africa Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 133. Israel Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 134. Israel Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 135. Turkey Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 136. Turkey Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 137. GCC Countries Anthrax Vaccines Consumption 2021-2025 (M Doses)
Figure 138. GCC Countries Anthrax Vaccines Value 2021-2025 ($ Millions)
Figure 139. Emergent BioSolutions Anthrax Vaccines Market Share (2018-2020)
Figure 140. CAVAC Anthrax Vaccines Market Share (2018-2020)
Figure 141. Merial Anthrax Vaccines Market Share (2018-2020)
Figure 142. Zoetis Anthrax Vaccines Market Share (2018-2020)
Figure 143. Bayer Sanidad Animal Anthrax Vaccines Market Share (2018-2020)
Figure 144. Merck Anthrax Vaccines Market Share (2018-2020)
Figure 145. Tiankang Anthrax Vaccines Market Share (2018-2020)
Figure 146. Colorado Serum Anthrax Vaccines Market Share (2018-2020)
Figure 147. Biogénesis-Bago Anthrax Vaccines Market Share (2018-2020)
Figure 148. PharmAthene Anthrax Vaccines Market Share (2018-2020)
Figure 149. Prondil Anthrax Vaccines Market Share (2018-2020)
Figure 150. Indian Immunologicals Anthrax Vaccines Market Share (2018-2020)
Figure 151. CDV Anthrax Vaccines Market Share (2018-2020)
Figure 152. Rosenbusch Anthrax Vaccines Market Share (2018-2020)
Figure 153. CVCRI Anthrax Vaccines Market Share (2018-2020)
Figure 154. Vecol Anthrax Vaccines Market Share (2018-2020)
Figure 155. Ceva Santé Animale Anthrax Vaccines Market Share (2018-2020)
Figure 156. IVPM Anthrax Vaccines Market Share (2018-2020)
Figure 157. Agrovet Anthrax Vaccines Market Share (2018-2020)
Figure 158. Botswana Vaccine Institute Anthrax Vaccines Market Share (2018-2020)
Figure 159. JOVAC Anthrax Vaccines Market Share (2018-2020)
Figure 160. Intervac Anthrax Vaccines Market Share (2018-2020)
Please feel free to write an email to us or to use our electronic ticketing system.
